Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R05FA02	TUSCALMAN A	B	Noscapine HCl - 5mg, Guaifenesin - 25mg		Suppository	624,963 L.L
R05FA02	TUSCALMAN B	B	Noscapine HCl - 10mg, Guaifenesin - 50mg		Suppository	615,992 L.L
C01DA02	TRINITRINA	G	Nitroglycerine - 50mg/50ml	50mg/50ml	Injectable concentrate for solution	6,212,584 L.L
L01EA03	TASIGNA	B	Nilotinib - 200mg	200mg	Capsule	412,535,139 L.L
L01EA03	TASIGNA	B	Nilotinib - 200mg	200mg	Capsule	L.L
L01EA03	TASIGNA	B	Nilotinib - 150mg	150mg	Capsule	323,961,910 L.L
L01EA03	TASIGNA	B	Nilotinib - 150mg	150mg	Capsule	L.L
P02DA01	TAENIASAN	G	Niclosamide - 500mg	500mg	Tablet	94,709 L.L
P02DA01	TENIADEX	G	Niclosamide - 500mg	500mg	Tablet	70,392 L.L
L04AA23	TYSABRI	BioTech	Natalizumab - 300mg/15ml	300mg/15ml	Injectable concentrated solution	126,830,594 L.L
R01AD09	TABUNEX	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
H03BB02	TAPAZOLE	B	Methimazole (Thiamazole) - 5mg	5mg	Tablet	565,694 L.L
H03BB02	THYROZOL	B	Methimazole (Thiamazole) - 5mg	5mg	Tablet, film coated	233,829 L.L
H03BB02	THYROZOL	B	Methimazole (Thiamazole) - 10mg	10mg	Tablet, film coated	326,554 L.L
J01AA04	TETRALYSAL	B	Lymecycline - 300mg	300mg	Capsule	796,899 L.L
C09AA03	TENSIKEY	G	Lisinopril - 5mg	5mg	Tablet	456,906 L.L
C09BA03	TENSIKEY COMPLEX	G	Lisinopril - 20mg, Hydrochlorothiazide - 12.5mg		Tablet	536,193 L.L
C09AA03	TENSIKEY	G	Lisinopril - 20mg	20mg	Tablet	460,938 L.L
A10BH05	TRAJENTA	B	Linagliptin - 5mg	5mg	Tablet, film coated	3,213,127 L.L
R02A	TRACHISAN	G	Lidocaine HCl - 1mg, Tyrothricin - 0.5mg, Chlorhexidine gluconate - 1mg		Lozenge	228,453 L.L
J01MA12	TAVANIC 500MG	B	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	1,988,887 L.L
J01MA12	TAVANIC	B	Levofloxacin - 500mg	500mg	Tablet, film-scored	1,150,329 L.L
J01MA12	TAVAQUIN 500MG	G	Levofloxacin - 500mg	500mg	Tablet, film coated	787,492 L.L
J01MA12	TAVAQUIN	G	Levofloxacin (hemihydrate) - 750mg	750mg	Tablet, film coated	1,389,533 L.L
L01EH01	TYKERB	B	Lapatinib ditosylate - 250mg	250mg	Tablet, film coated	101,971,611 L.L
B06AC05	TAKHZYRO	BioTech	Lanadelumab - 300mg/2ml		Injectable solution	1,204,227,927 L.L
J05AR12	TELADINE	G	Lamivudine - 300mg, Tenofovir disoproxil fumarate - 300mg		Tablet	17,454,739 L.L
N03AX18	TREPADIO	G	Lacosamide - 200mg/20ml	200mg/20ml	Injectable solution	9,569,390 L.L
L04AC13	TALTZ	BioTech	Ixekizumab - 80mg/ml	80mg/ml	Injectable solution	85,080,792 L.L
J02AC02	TRACON	G	Itraconazole - 100mg	100mg	Capsule	559,038 L.L

...